Parkinson's disease cognitive network correlates with caudate dopamine

Aarsland, 2010, The epidemiology of dementia associated with Parkinson disease, J. Neurol. Sci., 289, 18, 10.1016/j.jns.2009.08.034 Alves, 2006, Changes in motor subtype and risk for incident dementia in Parkinson's disease, Mov. Disord., 21, 1123, 10.1002/mds.20897 Bohnen, 2003, Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study, Arch. Neurol., 60, 1745, 10.1001/archneur.60.12.1745 Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 Bruck, 2005, Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease, Neurobiol. Aging, 26, 891, 10.1016/j.neurobiolaging.2004.07.014 Carbon, 2004, Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in parkinsonism, NeuroImage, 21, 1497, 10.1016/j.neuroimage.2003.12.014 Cheesman, 2005, Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, 76, 1204, 10.1136/jnnp.2004.055079 Cools, 2006, Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease, Neurosci. Biobehav. Rev., 30, 1, 10.1016/j.neubiorev.2005.03.024 Eidelberg, 2009, Metabolic brain networks in neurodegenerative disorders: a functional imaging approach, Trends Neurosci., 32, 548, 10.1016/j.tins.2009.06.003 Ekman, 2012, Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study, Lancet Neurol., 11, 679, 10.1016/S1474-4422(12)70138-2 Emre, 2004, Rivastigmine for dementia associated with Parkinson's disease, N. Engl. J. Med., 351, 2509, 10.1056/NEJMoa041470 Gotham, 1988, ‘Frontal’ cognitive function in patients with Parkinson's disease ‘on’ and ‘off’ levodopa, Brain, 111, 299, 10.1093/brain/111.2.299 Green, 2002, Cognitive impairments in advanced PD without dementia, Neurology, 59, 1320, 10.1212/01.WNL.0000031426.21683.E2 Hilker, 2005, Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways, Neurology, 65, 1716, 10.1212/01.wnl.0000191154.78131.f6 Hirano, 2010, PET imaging in movement disorders, 452 Hirano, 2012, Functional brain imaging of cognitive dysfunction in Parkinson's Disease, J. Neurol. Neurosurg. Psychiatry, 83, 963, 10.1136/jnnp-2011-301818 Hosokai, 2009, Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment, Mov. Disord., 24, 854, 10.1002/mds.22444 Huang, 2007, Metabolic brain networks associated with cognitive function in Parkinson's disease, NeuroImage, 34, 714, 10.1016/j.neuroimage.2006.09.003 Huang, 2007, Changes in network activity with the progression of Parkinson's disease, Brain, 130, 1834, 10.1093/brain/awm086 Huang, 2008, Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease, Neurology, 70, 1470, 10.1212/01.wnl.0000304050.05332.9c Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J. Neurol. Neurosurg. Psychiatry, 55, 181, 10.1136/jnnp.55.3.181 Ito, 2002, Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-l-dopa PET study, Brain, 125, 1358, 10.1093/brain/awf134 Jacobson, 1991, Clinical significance: a statistical approach to defining meaningful change in psychotherapy research, J. Consult. Clin. Psychol., 59, 12, 10.1037/0022-006X.59.1.12 Janvin, 2005, Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study, J. Geriatr. Psychiatry Neurol., 18, 149, 10.1177/0891988705277540 Jokinen, 2009, Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy, Parkinsonism Relat. Disord., 15, 88, 10.1016/j.parkreldis.2008.03.005 Kriegeskorte, 2009, Circular analysis in systems neuroscience: the dangers of double dipping, Nat. Neurosci., 12, 535, 10.1038/nn.2303 Kriegeskorte, 2010, Everything you never wanted to know about circular analysis, but were afraid to ask, J. Cereb. Blood Flow Metab., 30, 1551, 10.1038/jcbfm.2010.86 Looi, 2008, Caudate nucleus volumes in frontotemporal lobar degeneration: differential atrophy in subtypes, AJNR Am. J. Neuroradiol., 29, 1537, 10.3174/ajnr.A1168 Ma, 2002, Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study, Synapse, 45, 125, 10.1002/syn.10090 Ma, 2007, Abnormal metabolic network activity in Parkinson's disease: test–retest reproducibility, J. Cereb. Blood Flow Metab., 27, 597, 10.1038/sj.jcbfm.9600358 Maassen, 2004, The standard error in the Jacobson and Truax Reliable Change Index: the classical approach to the assessment of reliable change, J. Int. Neuropsychol. Soc., 10, 888, 10.1017/S1355617704106097 Mattis, 2011, Network correlates of the cognitive response to levodopa in Parkinson disease, Neurology, 77, 858, 10.1212/WNL.0b013e31822c6224 Muller, 2000, Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease, J. Neural Transm., 107, 303, 10.1007/s007020050025 Niethammer, 2012, Metabolic brain networks in translational neurology: concepts and applications, Ann. Neurol., 72, 635, 10.1002/ana.23631 O'Brien, 2004, Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies, Arch. Neurol., 61, 919, 10.1001/archneur.61.6.919 Pappata, 2011, Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism, Neurology, 77, 1357, 10.1212/WNL.0b013e3182315259 Polito, 2012, Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease, Neurobiol. Aging, 33, e229 Ribeiro, 2002, Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease, Arch. Neurol., 59, 580, 10.1001/archneur.59.4.580 Rinne, 2000, Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study, Arch. Neurol., 57, 470, 10.1001/archneur.57.4.470 Spetsieris, 2011, Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues, NeuroImage, 54, 2899, 10.1016/j.neuroimage.2010.10.025 Tang, 2010, Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease, J. Neurosci., 30, 1049, 10.1523/JNEUROSCI.4188-09.2010 Thobois, 2004, PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences, NeuroImage, 23, 1, 10.1016/j.neuroimage.2004.04.039 van Beilen, 2008, Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study, Parkinsonism Relat. Disord., 14, 224, 10.1016/j.parkreldis.2007.08.011 Vul, 2009, Puzzlingly high correlations in fMRI studies of emotion, personality, and social cognition, Perspect. Psychol. Sci., 4, 274, 10.1111/j.1745-6924.2009.01125.x